Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OTLYOatly Group AB | $11.26 | $1.07 | arrow_drop_up10.43% | $286.41M | 260.21K | 11.16 | - | Neutralremove | - | -51.44% | |||||
AKROAkero Therapeutics | $46.16 | -$2.76 | arrow_drop_down5.63% | $3.18B | 1.22M | 46.80 | - | Neutralremove | - | 125.18% | |||||
ALTGAlta Equipment Group | $4.77 | -$0.15 | arrow_drop_down3.13% | $179.89M | 97.91K | 4.80 | - | Neutralremove | 4.16% | -47.19% | |||||
 SMGScotts Miracle-Gro | $59.63 | -$1.09 | arrow_drop_down1.79% | $3.52B | 309.58K | 59.47 | - | Neutralremove | 4.51% | -10.24% | |||||
OLKOlink Holding AB | $26.08 | $0.00 | 0.00% | $3.24B | 0.00 | 1.01M | - | Sellkeyboard_arrow_down | - | 8.73% | |||||
NEWPNew Pacific Metals | $1.35 | $0.10 | arrow_drop_up8.40% | $194.11M | 347.27K | 1.33 | - | Neutralremove | - | -37.55% | |||||
FDMT4D Molecular Therapeutics | $3.43 | -$0.17 | arrow_drop_down4.86% | $148.23M | 250.33K | 3.45 | - | Neutralremove | - | -86.86% | |||||
VXRTVaxart | $0.46 | -$0.00 | arrow_drop_down1.10% | $96.88M | 654.51K | 0.45 | - | Neutralremove | - | -53.49% | |||||
 SLABSilicon Laboratories | $121.91 | -$1.12 | arrow_drop_down0.91% | $4.33B | 146.31K | 121.03 | - | Neutralremove | - | -4.44% | |||||
FRLA FRLAFortune Rise Acquisition | $11.64 | $11.64 | 0.00% | $36.81M | 13.00 | 11.39 | - | Neutralremove | - | 3.68% | |||||
NOTEFiscalNote Holdings | $0.63 | -$0.02 | arrow_drop_down3.14% | $108.10M | 1.77M | 0.65 | - | Neutralremove | - | -58.00% | |||||
BCOVBrightcove | $4.45 | $0.02 | arrow_drop_up0.45% | $202.09M | 301.25K | 4.44 | - | Neutralremove | - | 109.15% | |||||
NRDYNerdy | $1.60 | $0.01 | arrow_drop_up0.94% | $210.79M | 356.01K | 1.58 | - | Neutralremove | - | -15.52% | |||||
CATXPerspective Therapeutics, Inc. Common Stock | $2.43 | -$0.07 | arrow_drop_down2.98% | $178.89M | 398.11K | 2.50 | - | Neutralremove | - | -83.65% | |||||
AXNXAxonics Modulation Technologies | $70.98 | $0.53 | arrow_drop_up0.75% | $48.04B | 4.23M | 70.91 | - | Sellkeyboard_arrow_down | - | 4.95% | |||||
HSPO HSPOUHORIZON SPACE ACQUISITION I CORP UNIT 1 ORD 1 WT & 1 RT | $11.12 | $11.12 | 0.00% | $101.18M | 0.00 | 0.00 | - | Neutralremove | - | 2.01% | |||||
CUENCuentas | $0.11 | $0.01 | arrow_drop_up19.00% | $27.30K | 9.20K | 7.14K | - | Neutralremove | - | -66.00% | |||||
OCGNOcugen | $0.91 | $0.01 | arrow_drop_up1.24% | $207.13M | 8.89M | 0.95 | - | Neutralremove | - | -46.91% | |||||
IMMXImmix Biopharma, Inc. Common Stock | $1.99 | -$0.40 | arrow_drop_down16.80% | $58.26M | 1.07M | 2.01 | - | Sellkeyboard_arrow_down | - | -7.20% | |||||
INSGInseego | $8.14 | -$0.03 | arrow_drop_down0.36% | $116.00M | 60.19K | 8.18 | - | Neutralremove | - | 20.83% |
Showing 4921-4940 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools